OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
04 nov 2010 - 07:15
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus appoints Jan Hendrik Egberts as CEO
Bericht
OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), the drug delivery company, is pleased to announce that its Board of Supervisory Directors has hired Jan Hendrik Egberts, M.D. and nominated him for appointment as Chief Executive Officer at the Annual General Meeting of Shareholders in the spring of 2011. He will replace OctoPlus’ current CEO Simon Sturge, who will leave the Company as per 1 January 2011 to lead a large division in a top-15 pharmaceutical company. Dr. Egberts will immediately start working together with Mr. Sturge until the end of this year to ensure a smooth transition.
Datum laatste update: 01 september 2024